Jagsonpal Pharmaceuticals Ltd 2026 Annual Report with Sustainability Disclosures
Company: Jagsonpal Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2026
Type: Annual Report with Sustainability Disclosures
Pages: 173
The report presents FY26 revenue of ₹2,872 million and describes continued portfolio growth. It reports one workplace fatality and 39.122 metric tonnes of hazardous waste disposed through incineration. CSR initiatives included 20 girls' toilets benefiting approximately 9,576 people and broader women's health and sanitation programs.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.